This is a past event. Registration is closed. View other AmCham China events.
Join AmCham China for a discussion on the biopharmaceutical industry featuring Amy Wendholt from APCO Worldwide. Wendholt will share APCO's latest research from the benchmark Asia-Pacific "Return on Reputation (ROR) Study: State of the Biopharmaceutical Industry". The ROR study seeks to better understand the expectations key stakeholders have of companies operating in the biopharmaceutical industry.
The study includes input from the top 12 multinational biopharmaceutical companies operating in the region. It is based on a quantitative survey conducted among more than 1,500 stakeholders, including healthcare opinion leaders, healthcare providers, policy leaders and payers in China, Japan, Korea, India and Australia.
